UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000025672
Receipt number R000029533
Scientific Title Wasure-NAVI-to for a better dementia and MCI patient care.
Date of disclosure of the study information 2017/01/16
Last modified on 2018/01/16 19:20:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Wasure-NAVI-to for a better dementia and MCI patient care.

Acronym

Wasure-Navi-to

Scientific Title

Wasure-NAVI-to for a better dementia and MCI patient care.

Scientific Title:Acronym

Wasure-Navi-to

Region

Japan


Condition

Condition

mild cognitive impairment, dementia

Classification by specialty

Neurology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

People with dementia or mild cognitive impairment (MCI) need personalized care, especially because their symptoms arise from their past experience and current relationships with their families and friends. In Japanese outpatient clinic settings, sessions for each patient tend to be very brief owing to the large number of patients visiting hospitals; quite often, sessions are as short as three minutes and can only be held once every three months. Unlike other diseases that physicians deal with, this is not tolerable at all, because it is obvious that under these circumstances it is almost impossible to obtain personal information or give personal advice. Professionals involved in dementia care range from physicians to community volunteers; sharing patient background information or current status among those individuals is extremely important. However, in addition to the previously mentioned limitations, person-to-person or community based approaches are becoming increasingly difficult in urban settings. Thus, better dementia care requires better communication tools that also assure secure information exchange.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Research satisfaction Survey

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Usage of ICT tablet

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

patients with diagnosis of mild cognitive impairment or dementia and their primary caregiver.

Key exclusion criteria

subjects without consent

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Atsushi Iwata

Organization

The University of Tokyo Hospital

Division name

Department of Neurology

Zip code


Address

7-3-1 Hongo Bunkyo-ku, Tokyo

TEL

03-5800-8672

Email

iwata@m.u-tokyo.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Atsushi Iwata

Organization

The University of Tokyo Hospital

Division name

Department of Neurology

Zip code


Address

7-3-1 Hongo Bunkyo-ku, Tokyo

TEL

03-5800-8672

Homepage URL


Email

iwata@m.u-tokyo.ac.jp


Sponsor or person

Institute

Japan Science and Technology Agency

Institute

Department

Personal name



Funding Source

Organization

Japan Science and Technology Agency

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 01 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 04 Month 11 Day

Date of IRB


Anticipated trial start date

2016 Year 05 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 01 Month 14 Day

Last modified on

2018 Year 01 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029533


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name